View all IQVIA events


Inflation Reduction Act (IRA) implementation is leading to transformational changes in the life sciences industry. Medicare recently selected the first 10 products that will be subject to price negotiations, which will show implications throughout the products' lifecycle. The need for more evidence at launch to accelerate adoption for the right indications will be a key driver for strategic considerations in the US market and beyond.
Webinar attendees will: